The global alcohol use disorder treatment market is entering a period of significant expansion, driven by increasing mental health awareness, advancements in addiction treatment, and proactive ...

The global babesiosis treatment market is expected to witness significant growth over the next decade, fueled by rising infection rates, especially in tick-endemic regions, and ongoing innovation in ...

The global biosensors market is on an impressive growth trajectory, with its valuation expected to reach USD 31.8 billion in 2025 and soar to USD 76.2 billion by 2035, expanding at a Compound Annual ...

The central pain syndrome management market is set to experience remarkable growth over the next decade. Valued at USD 66,100 Million in 2025, the market is projected to reach USD 1,02,700 Million by ...

The global durable medical equipment rental market is entering a transformative growth phase, projected to rise from approximately USD 30,184 million in 2025 to USD 53,495 million by 2035, expanding ...

LAS CRUCES, NEW MEXICO / ACCESS Newswire / April 29, 2025 / As newly appointed CMS Administrator Dr. Mehmet Oz renews focus ...

Biomanufacturers producing protein biologics including complex modalities, will have access to a full suite of custom cell ...

New manufacturing deal positions CBDL to tap into the $4.9 billion Latin American CBD market, unlocking major revenue growth ...

Independent Surveys Rank Top ASC Vendors for Client Satisfaction and User Experience Across 18 Key Performance Indicators DENVER, CO / ACCESS Newswire / April 29, 2025 / Black Book Research, the ...

VANCOUVER, BC / ACCESS Newswire / April 29, 2025 / UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc" or the "Company"), provides an update on its renewed engagement of Rumble Strip Media ...

StudyAbivax Announces Completion of Enrollment for the Phase 3 ABTECT Trials in Patients with Moderately to Severely Active Ulcerative Colitis 29.04.2025 / 22:05 CET/CESTThe issuer is solely ...

The webcast will review the MVID and SBS-IF patient experience, the impact of crofelemer on disease progression and quality of life in MVID and SBS-IF, and possible expedited regulatory pathways for ...